NCT02453529View on ClinicalTrials.gov

Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy
Interventions
DRUG

WCK 4873

Oral tablets

Trial Locations (1)

85006

Pulmonary Associates, 1112 E. McDowell Rd., Phoenix

Sponsors

Lead Sponsor

Wockhardt

Collaborators (1)

Clinartis
All Listed Sponsors
collaborator

Clinartis

INDUSTRY

lead

Wockhardt

INDUSTRY